| INTRODUCTION
In-stent restenosis (ISR) has been a longstanding problem after percutaneous coronary intervention. The advent of drug-eluting stents (DESs) significantly reduced the incidence of restenosis and target lesion revascularization in a wide variety of clinical situations.
However, even in the DES era, ISR remains a significant clinical problem, and poses a treatment challenge particularly for high-risk lesions. 1 Significant disparities in neointimal response and vascular healing among the current leading polymeric DES have been showed in multiple histopathological, preclinical, and clinical studies. 2, 3 Therefore, differences in stent platforms, polymer coatings, and antirestenotic drugs among the current in use second generations drug eluting stents (G2-DES) may induce significant variations in neointimal response and vascular healing. This may have an impact on the morphological appearance of the restenotic tissue, especially if implanted in complex rather than simple coronary lesions; however, these speculations have not been fully characterized.
Moreover, the correlation between the angiographic and procedural characteristics of restenotic lesions at the time of stent implantations and the optical coherence tomography (OCT) appearance of restenotic tissue has been poorly represented.
OCT is a high-resolution imaging modality capable of investigating detailed vascular healing after stent implantation. This unparalleled image resolution, which is approximately 10 times higher than that of IVUS, can evaluate plaque morphology with sensitivity close to histology and provide an accurate assessment of stent deployment. 4 Moreover, OCT has been used for the characterization of different tissue pattern, 5 and can depict distinct patterns of in-stent hyperplasia like neoatherosclerosis. 6 The current study utilized the high-resolution imaging capabilities of the 3rd generation optical frequency domain imaging (OFDI) to demystify the prevalence of NA, and the morphological appearance, and tissue characteristics of restenosis lesions following the liberal implantation of G2-DESs in unrestricted coronary lesions.
| MATERIALS AND METHODS

| Patients and lesions
This was a retrospective observational analysis of denovo G2-DES
ISR lesions undergoing target lesion revascularization (TLR),
between April 2013 and March 2014. ISR was defined as a diameter stenosis >50% within the stent segment. Patients with one or more first ISR with a G2-DES who were scheduled for percutaneous revascularization based on ischemic symptoms and/or impaired perfusion detected by non-invasive tools were enrolled in this study.
Four types of DESs were available throughout the study period:
biolimus-eluting stents (BESs) (Nobori, Terumo, Tokyo, Japan), Cobalt-chromium everolimus-eluting stent (CoCr-EESs, XIENCE V, Abbott Vascular, Santa Clara, CA), and platinum-chromium everolimus-eluting stents (PtCr-EESs, Promus Element, Boston Scientific, Natick, MA), and zotarolimus-eluting stents (Resolute, Medtronic, Santa Rosa, CA). The selection of the DES at the time of implantation was at the physician's discretion. To figure out the effect of the initial lesion characteristics on the morphological appearance of the restenotic tissue, we evaluated the angiographic and procedural characteristics at the index procedures of stent implantations.
Importantly, clinical, angiographic, and procedural data of the studied population/stents were reviewed twice; at the time of implantation as well as at the time of TLR.
OFDI was not performed for (i) ISR lesions with first generation DESs (G1-DESs) or bare metal stents (BMS); (ii) ISR lesions presenting with chronic total occlusions; (iii) ISR lesions causing ST-segment elevation myocardial infarctions; and (iv) ISR lesions in patients presenting with cardiogenic shock. There were no exclusions based on the lesion morphology and/or complexity. All patients were advised to maintain using dual antiplatelet, statins, and other anti-ischemic drugs as described by their treating physician.
Short-term follow-up angiography was performed as indicated by:
(i) the scheduled follow-up of the implanted stent; or (ii) evidence of myocardial ischemia detected either clinically or by non-invasive tools.
Long-term follow-up angiography (>1 year) was performed due to: (i) the scheduled follow up of other treated segments; or (ii) evidence of myocardial ischemia. In our center, intracoronary imaging (intravascular ultrasound [IVUS] or OFDI) was performed in all ISR lesions to demystify the mechanism of restenosis and to guide the therapeutic decision. A prospective protocol was approved by the institutional review board to perform an OFDI study in patients with ISR on coronary angiography deemed eligible for percutaneous revascularization. All patients gave their informed consent before the intervention.
| Quantitative angiographic analysis
A quantitative coronary angiographic (QCA) analysis was performed with an automatic edge-detection system (MEDIS, QCA-CMS version 6, Netherlands). The QCA was performed through the in-stent segment and the adjacent proximal and distal 5-mm vessel segment.
Quantitative measurements, at the time of the stent deployment and at the time of the OFDI analysis, were assessed by an independent evaluator who was blinded to the patient characteristics and study outcomes using the same standards previously reported. 7 The angiographic restenotic lesion type was classified according to the Mehran's classification. 8 Overlapping and consecutive stents were considered as one lesion, while stents separated by more than 5 mm were considered as separate lesions.
| Optical frequency domain imaging: Image acquisition
Following the angiography and successful guidewire crossing, and before any intervention, all ISR lesions were evaluated using the FastView OFDI catheter and LUNAWAVE™ OFDI system (Terumo Corp. Tokyo, Japan), Detailed OFDI image acquisition was reported elsewhere. 9 All acquired data were saved in the machine console for In addition, we also evaluated peri-strut low intensity area (PLIA), defined as a region around stent struts with homogenous lower intensity than surrounding tissue on OCT images without signal attenuation, 15, 8 ( Fig. 2 ; I) and neovascularization, which was defined as small vesicular or tubular structures differentiated from any side branches with a diameter <200 µm. Neovascularization was classified into intra-intima ( Fig. 2 ; III) or peri-stent by the location of the microvessels. 11 Intimal intactness was evaluated as (i) intact intima; or
(ii) disrupted intima (discontinuity of lumen border) with a visible cavity ( Fig. 2 ; II*).
| Reproducibility assessment of the image analysis
All selected cross-sectional images were evaluated independently by each observer at a different time points. Different qualitative interpretations were then reevaluated, and consensus between the two observers has to be reached. To assess the interobserver variability of the qualitative OCT analysis, one of the observers repeated the analysis of all images 1 month later.
| Statistical analysis
Categorical variables were expressed as numbers and percentages whereas continuous variables were described as the mean ± 1 SD.
Comparisons between groups were performed with a one-way ANOVA test for continuous variables and with χ 2 or Fisher's exact test for categorical variables, while subgroup differences were ascertained using a Tukey's test. The inter-observer agreement (between the two reviewers) for the discrimination of the tissue characterization, 
| Baseline patients, angiographic, and lesions characteristics
The baseline patient demographics during the index procedures of the stent implantations are described in Table 1 . Most of our population were males (76%) with a mean age of 69 years. The included patients had high coronary risk factors: diabetes mellitus (42%), hypertension (82%), and dyslipidemia (78%) with no statistical in between groups differences. Patients with PtCr-EESs were more likely to have renal impairment (P = 0.07), and oftentimes were on hemodialysis (P = 0.01).
Recurrent stable angina was the most common indication for TLR among all groups. All patients were similarly maintained on antiplatlets and antiischmic medications for the recorded period of follow-up with no significant differences between groups.
The angiographic and procedural characteristics at the index procedures are shown in Table 2 . There were no significant differences between groups in the lesion or procedural characteristics. Moreover, quantitative stent measurements as well as post stenting balloon The studied G2-DESs were initially deployed in angiographically complex Lesions; 54% were type C lesions, 22% were angulated, 22%
in bifurcation lesions, 20% in ostial lesions, and 40% of the stents (20 out of 50 ISR) were implanted primarily in recanalized chronic total occlusion lesions with no difference between all groups. Of note, more than 2/3 of the analyzed stents were originally implanted with IVUS optimization (range 55-80%). QCA analyses are summarized in Table 3 .
While Focal restenosis is predominant in all G2 DES (64%), there were no significant differences in either restenotic pattern or quantitative measurements between various groups (Table 4 ). The articulation gap Values are presented as n (%) or mean ± SD; P-value is calculated by one way ANOVA. ACS, acute coronary syndrome; BESs, biolimus-eluting stents; BMI, body mass index; CABG, coronary artery bypass graft; CoCr-EESs, Cobalt-chromium everolimus-eluting stent; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; PtCr-EESs, platinum-chromium everolimus-eluting stents. 
| OFDI analysis
Qualitative and quantitative OFDI results are described in details in Table 5 . There were no significant differences in morphological appearance and tissue characteristics among all G2-DES. Nearly half of all ISR lesions (24/50) had neoatherosclerosis with no significant differences between groups (41%, 69%, and 40% in CoCr, PtCr, and BES respectively, P = 0.22). Moreover, the other qualitative variables associated with NA such as, microvessels and PLLA were similarly observed in all G-DES subtypes. Of note, 56% of the restenotic tissue had a heterogeneous intima; of these, 14 lesions (50%) were layered pattern. Thirty-one ISR lesions (62%) had high backscatter. Stent deployment parameters (Stent symmetry index and stent eccentricity index) were optimum in all studied stents (Table 5) ; No lesions with stent malapposition could be identified. Furthermore, there were no significant differences in the prevalence of NA nor there any significant differences in the morphological appearance and tissue characteristics between early (<1 year) and late (>1 year) in-stent restenotic phases.
As for the comparison between the total EESs (CoCr-EESs and
PtCr-EESs) and BESs, there were no significant differences in patient or lesions characteristics. Similarly, neither differences in morphological appearance of NIH nor quantitative differences were observed between the two groups. Of note, Heterogeneous intima with either layered or patchy pattern was predominant in patients with renal impairment (five out of seven lesions, 71%).
On the other hand, there was no significant differences between focal and diffuse ISR patterns as regard to the morphological patterns, where 41% of the focal ISR lesions had homogenous intima versus 50% of the diffuse ones (P = 0.56). Moreover, as regard to the correlation between the angiographic restenosis pattern and the neoatherosclerosis (NA); NA was more likely observed in focal ISR patterns, however, it did not reach statistical significance (53% vs. 39%
in focal and diffuse patterns respectively, P = 0.38). Values are mean ± SD or n (%). MLD, minimum lumen diameter; %DS, percent diameter stenosis. TLR, Target lesion revascularization; other abbreviations are as Table 1 .
a Measurements and proportions were calculated from the number of lesions which had follow up angiography.
TABLE 4 Angiographic restenotic patterns
CoCr-EESs (n = 22) BESs (n = 15) PtCr-EESs (n = 13) P value 
| DISCUSSION
The main findings of the current study are, (i) neoatherosclerosis (NA)
was observed in about half of all G2-DES-treated lesions and was similarly demonstrated in early and late ISR lesions, and (ii) the morphological appearance and tissue characteristics of the restenotic lesions were similar among the various types of G2-DES, when implanted originally in complex coronary lesions.
In-stent neoatherosclerosis is histologically characterized by neointima tissue that contains an accumulation of lipid-laden foamy macrophages with or without necrotic core formation and/or calcification. 16 In-stent neoatherosclerosis (NA) was observed in DESs more frequently and at an earlier time point as compared with BMSs. 16 Accordingly, NA has been regarded as a primary mechanism for late stent failure after DES implantations. 6 Our observed rate of NA was comparable to the previous reports among G2-DESs, 17, 18 and also similar to what has been observed among the first-generation DES. 5 The recent human autopsy study showed that the frequency of neoatherosclerosis did not differ significantly between CoCr-EES and first-generation DESs. 18 Conversely, Lee et al 19 the individual subtypes of G2-DES. This is in line with the recent data from Tada et al, 11 who demonstrated that the healing patterns of BESs with a biodegradable polymer were similar to that of EESs with a permanent polymer as assessed by OCT at 6-8 months.
Moreover, angiographic features of the lesion complexity not only determine the ISR severity, but it may also affect its morphological appearance. 22 Complex lesion characteristics and underlying unstable plaque morphologies are associated with greater delayed healing after first-generation DES placement compared with simple and stable coronary artery disease lesions. 23, 24 Therefore, the lack of significant differences in the OFDI morphological appearance and tissue characteristics among the different G2-DESs in our study may reflect the large impact of the original disease severity and primary lesion complexity on the neointimal tissue appearance and vascular response irrespective of the implanted polymer or antirestenotic drug.
Nevertheless, despite the fact that angiographically determined lesion complexity correlates closely with pathological plaque instability, such plaques may remain stable over time. 25 In essence the dichotomous distinction in homogeneous and heterogeneous patterns does not have a clinical correlation by itself. A serial OCT study of G2-DES, 20 has shown that, in lesions with NIH regression, the evolution of a heterogeneous to homogeneous neointima was observed, while the evolution of a heterogeneous or homogeneous to a layered neointima, or the evolution of a heterogeneous, homogeneous, or layered neointima to neoatherosclerosis was evident in lesions with NIH progression. These changes in neointimal characteristics probably indicate different pathological vessel healing mechanisms at different time points after G2-DES implantation, or may be contributable to the different optical properties of the utilized OFDI system (FastView OFDI catheter, LUNAWAVE™" Terumo Corp. Tokyo, Japan) in our study which has an excellent image resolution (160 frame/sec) with a very high pull back speed as compared with the previous generations of OCT, used in prior studies. 19, 13 Whether these machine differences impact the appearance of the NIH or lead to variable light attenuation when traveling through tissues remain to be comparatively evaluated.
| LIMITATIONS
This retrospective study had several limitations including pitfalls correlated to the nature of any retrospective registry enrolling selected patients with an angiographically significant stenosis and only patients with an OCT evaluation at the time of the TLR were included, thus a selection bias may have affected our results. Further studies with a larger number of DES-treated patients and a comparable stent age are recommended.
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